SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending following the official announcement that the stock will be added to the S&P 500, a milestone that has triggered significant after-hours price appreciation and widespread community debate. Investors are actively discussing the potential impact of index fund buying, with many debating whether the inclusion acts as a sustainable momentum catalyst or a signal for a short-term 'sell the news' fade.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is trending after reporting strong quarterly results and raising forward guidance, which has spurred significant debate among investors regarding whether the AI-driven capex boom is fully priced in. The community is actively discussing the stock's volatility, with many debating the impact of semiconductor cyclicality and institutional positioning on its recent price performance.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is facing downward pressure following a analyst downgrade related to executive turnover, though shareholders are viewing the dip as an attractive entry point given the company's strong fundamentals and ongoing international expansion. Investors are actively debating the impact of the new CFO appointment, with many dismissive of the negative sentiment and emphasizing the stock's significant long-term potential in the fintech sector.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is seeing a wave of bullish sentiment driven by significant insider accumulation, with multiple executives, including the CEO, making major open-market purchases as the stock trades at multi-year lows. Investors are actively debating whether this cluster of insider buying and recent technical support levels signal a definitive long-term bottom, despite ongoing volatility and concerns surrounding procedure volume growth.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors focus on upcoming regulatory milestones, including an anticipated BLA submission for its prostate cancer therapy, alongside growing institutional accumulation and positive updates from clinical manufacturing progress. The community is actively discussing the stock's buyout potential and significant addressable market while monitoring ongoing technical breakouts and the company's strong institutional backing.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc is trending as investors weigh its direct role in Dell's AI infrastructure buildout against concerns over high customer concentration and recent earnings volatility. While some community members are betting on a turnaround driven by facility expansions and systems integration growth, others remain skeptical due to the company's lack of revenue diversification and history of post-earnings price slides.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is surging as investors closely monitor the drone sector for anticipated government contract awards and increased domestic defense spending. The community is actively discussing the company's strategic manufacturing expansion and its role as an NDAA-compliant supplier, with many speculating on the impact of future federal equity stakes or procurement deals on the stock's long-term trajectory.

York Space Systems, Inc. engages in providing a comprehensive suite of mission-critical solutions for national security, government, and commercial customers. It offers a vertically integrated, full technology stack of solutions including design, production, integration, and operation of spacecraft with turnkey offerings to manage spacecraft and constellations throughout the entire mission lifecycle. The company was founded by Dirk Wallinger in January 2012 and is headquartered in Denver, CO.

York Space Systems Inc

York Space Systems is drawing significant investor interest following its recent Q2 earnings report and a sharp after-hours price decline, which has triggered debates over the company's lowered fiscal guidance and the departure of its CFO. While some investors are treating the volatility as a buying opportunity given the firm's defense-focused backlog, others are expressing caution due to high dilution, institutional selling, and ongoing skepticism regarding management's ability to navigate competitive procurement cycles.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals is experiencing significant volatility and downward pressure as investors react to the company's high cash burn rate and underwhelming commercial performance. The community is actively debating the stock's future, with many retail investors expressing frustration over management, while others closely watch for potential institutional shifts and the impact of looming competition.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is gaining significant investor attention due to its status as a highly undervalued cybersecurity pure-play, with many market participants viewing its current valuation as a prime setup for a major tech acquisition or a significant valuation re-rate. Community discussions are heavily centered on the company's superior balance sheet, strategic AI integration, and the potential windfall from its equity stake in Anthropic as a key catalyst for long-term upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises

Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.

Bio-Techne Corrects Dividend Announcement

Bio-Techne Corrects Dividend Announcement Bio-Techne Corrects Dividend Announcement PR Newswire MINNEAPOLIS, Aug. 13, 2026 MINNEAPOLIS, Aug. 13, 2026 /PRNewswire/ -- Bio-TechneCorporation(NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version...

Techne (TECH) Q4 Earnings Meet Estimates

Techne (TECH) delivered earnings and revenue surprises of 0.00% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Bio-Techne Posts Q4 Net Profit As Expenses Drop, Net Sales Improve

(RTTNews) - Bio-Techne Corporation (TECH), a provider of life science reagents, instruments, and services, on Wednesday reported net profit for the fourth quarter of fiscal 2026...

Bio-Techne Declares Dividend

Bio-Techne Declares Dividend Bio-Techne Declares Dividend PR Newswire MINNEAPOLIS, Aug. 12, 2026 MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-TechneCorporation(NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026...

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results Bio-Techne Releases Fourth Quarter Fiscal 2026 Results PR Newswire MINNEAPOLIS, Aug. 12, 2026 MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending...

JAZZ vs. TECH: Which Stock Is the Better Value Option?

Investors' Confidence in Bio-Techne Corp. (TECH) Strengthens as Headwind Eases

Investors' Confidence in Bio-Techne Corp. (TECH) Strengthens as Headwind Eases...

Can These 3 MedTech Stocks Hit Targets This Earnings Season?

Can Zimmer Biomet, Charles River Laboratories and Bio-Techne meet earnings expectations? See the MedTech trends and company-specific drivers in focus.

Bio-Techne's Q4 Earnings on Deck: What's in Store for the Stock?

TECH heads into fiscal fourth-quarter earnings with revenues expected to remain flat, EPS projected to decline, and its $11.3 billion acquisition deal in focus.

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Bio-Techne Corp

Are AMZN Shares Poised For A 9-Day Losing Streak? Here’s What Retail Thinks

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '27	$0.44	--	--	N/A
Q4 '26	$0.52	$0.52	0.12%	BEAT
Q3 '26	$0.53	$0.53	-0.79%	MISSED
Q2 '26	$0.43	$0.46	6.00%	BEAT
Q1 '26	$0.42	$0.42	-0.33%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '26

Historical Earnings